nodes	percent_of_prediction	percent_of_DWPC	metapath
Carglumic Acid—CPS1—retina—acquired immunodeficiency syndrome	0.0526	0.184	CbGeAlD
Carglumic Acid—CPS1—digestive system—acquired immunodeficiency syndrome	0.0369	0.129	CbGeAlD
Carglumic Acid—CPS1—spinal cord—acquired immunodeficiency syndrome	0.0339	0.119	CbGeAlD
Carglumic Acid—CPS1—vagina—acquired immunodeficiency syndrome	0.0326	0.114	CbGeAlD
Carglumic Acid—CPS1—lung—acquired immunodeficiency syndrome	0.0309	0.108	CbGeAlD
Carglumic Acid—CPS1—nervous system—acquired immunodeficiency syndrome	0.0286	0.0999	CbGeAlD
Carglumic Acid—CPS1—central nervous system—acquired immunodeficiency syndrome	0.0275	0.0962	CbGeAlD
Carglumic Acid—CPS1—brain—acquired immunodeficiency syndrome	0.0218	0.0764	CbGeAlD
Carglumic Acid—CPS1—lymph node—acquired immunodeficiency syndrome	0.0211	0.0738	CbGeAlD
Carglumic Acid—Infestation—Efavirenz—acquired immunodeficiency syndrome	0.00337	0.00472	CcSEcCtD
Carglumic Acid—Influenza—Ritonavir—acquired immunodeficiency syndrome	0.00334	0.00468	CcSEcCtD
Carglumic Acid—Anaemia—Nevirapine—acquired immunodeficiency syndrome	0.0033	0.00462	CcSEcCtD
Carglumic Acid—Pneumonia—Delavirdine—acquired immunodeficiency syndrome	0.00324	0.00454	CcSEcCtD
Carglumic Acid—Infection—Didanosine—acquired immunodeficiency syndrome	0.00322	0.00451	CcSEcCtD
Carglumic Acid—Influenza—Saquinavir—acquired immunodeficiency syndrome	0.00322	0.00451	CcSEcCtD
Carglumic Acid—Anaemia—Nelfinavir—acquired immunodeficiency syndrome	0.0032	0.00448	CcSEcCtD
Carglumic Acid—Cardiac disorder—Zidovudine—acquired immunodeficiency syndrome	0.0032	0.00448	CcSEcCtD
Carglumic Acid—Anaemia—Stavudine—acquired immunodeficiency syndrome	0.00319	0.00446	CcSEcCtD
Carglumic Acid—Nasopharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.00318	0.00445	CcSEcCtD
Carglumic Acid—Anaemia—Abacavir—acquired immunodeficiency syndrome	0.00314	0.0044	CcSEcCtD
Carglumic Acid—Sweating increased—Saquinavir—acquired immunodeficiency syndrome	0.00314	0.00439	CcSEcCtD
Carglumic Acid—Decreased appetite—Amprenavir—acquired immunodeficiency syndrome	0.00309	0.00433	CcSEcCtD
Carglumic Acid—Anorexia—Didanosine—acquired immunodeficiency syndrome	0.00309	0.00433	CcSEcCtD
Carglumic Acid—Influenza—Lamivudine—acquired immunodeficiency syndrome	0.00307	0.0043	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.00307	0.0043	CcSEcCtD
Carglumic Acid—Weight decreased—Ritonavir—acquired immunodeficiency syndrome	0.00303	0.00424	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.00302	0.00423	CcSEcCtD
Carglumic Acid—Malnutrition—Zidovudine—acquired immunodeficiency syndrome	0.003	0.0042	CcSEcCtD
Carglumic Acid—Sweating increased—Lamivudine—acquired immunodeficiency syndrome	0.00299	0.00419	CcSEcCtD
Carglumic Acid—Bradycardia—Delavirdine—acquired immunodeficiency syndrome	0.00295	0.00413	CcSEcCtD
Carglumic Acid—Dysgeusia—Zidovudine—acquired immunodeficiency syndrome	0.00294	0.00411	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.00292	0.0041	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.00292	0.00408	CcSEcCtD
Carglumic Acid—Weight decreased—Saquinavir—acquired immunodeficiency syndrome	0.00291	0.00408	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.00291	0.00407	CcSEcCtD
Carglumic Acid—Pneumonia—Saquinavir—acquired immunodeficiency syndrome	0.00289	0.00404	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.00287	0.00402	CcSEcCtD
Carglumic Acid—Infestation—Saquinavir—acquired immunodeficiency syndrome	0.00287	0.00402	CcSEcCtD
Carglumic Acid—Infestation NOS—Saquinavir—acquired immunodeficiency syndrome	0.00287	0.00402	CcSEcCtD
Carglumic Acid—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00286	0.004	CcSEcCtD
Carglumic Acid—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.00283	0.00397	CcSEcCtD
Carglumic Acid—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.00282	0.00395	CcSEcCtD
Carglumic Acid—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.00281	0.00394	CcSEcCtD
Carglumic Acid—Cardiac disorder—Efavirenz—acquired immunodeficiency syndrome	0.00281	0.00393	CcSEcCtD
Carglumic Acid—Malnutrition—Indinavir—acquired immunodeficiency syndrome	0.00279	0.0039	CcSEcCtD
Carglumic Acid—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.00278	0.00389	CcSEcCtD
Carglumic Acid—Anaemia—Zidovudine—acquired immunodeficiency syndrome	0.00277	0.00388	CcSEcCtD
Carglumic Acid—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.00276	0.00387	CcSEcCtD
Carglumic Acid—Infection—Abacavir—acquired immunodeficiency syndrome	0.00275	0.00386	CcSEcCtD
Carglumic Acid—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00274	0.00384	CcSEcCtD
Carglumic Acid—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.00273	0.00383	CcSEcCtD
Carglumic Acid—Dysgeusia—Indinavir—acquired immunodeficiency syndrome	0.00273	0.00382	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.00273	0.00382	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.00272	0.00381	CcSEcCtD
Carglumic Acid—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.00272	0.00381	CcSEcCtD
Carglumic Acid—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.00269	0.00377	CcSEcCtD
Carglumic Acid—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.00269	0.00377	CcSEcCtD
Carglumic Acid—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.00268	0.00376	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.00265	0.00371	CcSEcCtD
Carglumic Acid—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.00264	0.0037	CcSEcCtD
Carglumic Acid—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.00263	0.00369	CcSEcCtD
Carglumic Acid—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.00259	0.00363	CcSEcCtD
Carglumic Acid—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.00258	0.00361	CcSEcCtD
Carglumic Acid—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.00258	0.00361	CcSEcCtD
Carglumic Acid—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00256	0.00359	CcSEcCtD
Carglumic Acid—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00256	0.00359	CcSEcCtD
Carglumic Acid—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00255	0.00357	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.00253	0.00355	CcSEcCtD
Carglumic Acid—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.00253	0.00355	CcSEcCtD
Carglumic Acid—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.00252	0.00353	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00252	0.00352	CcSEcCtD
Carglumic Acid—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.00251	0.00351	CcSEcCtD
Carglumic Acid—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.0025	0.0035	CcSEcCtD
Carglumic Acid—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.00248	0.00348	CcSEcCtD
Carglumic Acid—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.00247	0.00346	CcSEcCtD
Carglumic Acid—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.00245	0.00344	CcSEcCtD
Carglumic Acid—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.00245	0.00343	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00244	0.00341	CcSEcCtD
Carglumic Acid—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.00243	0.00341	CcSEcCtD
Carglumic Acid—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00243	0.00341	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00243	0.0034	CcSEcCtD
Carglumic Acid—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.00241	0.00338	CcSEcCtD
Carglumic Acid—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.0024	0.00336	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00239	0.00335	CcSEcCtD
Carglumic Acid—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.00239	0.00335	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.00238	0.00334	CcSEcCtD
Carglumic Acid—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00238	0.00333	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00236	0.00331	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00236	0.0033	CcSEcCtD
Carglumic Acid—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.00233	0.00327	CcSEcCtD
Carglumic Acid—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.00233	0.00326	CcSEcCtD
Carglumic Acid—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.00233	0.00326	CcSEcCtD
Carglumic Acid—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00233	0.00326	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00231	0.00323	CcSEcCtD
Carglumic Acid—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.0023	0.00323	CcSEcCtD
Carglumic Acid—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.0023	0.00323	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.0023	0.00322	CcSEcCtD
Carglumic Acid—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.00228	0.0032	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00227	0.00318	CcSEcCtD
Carglumic Acid—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00226	0.00317	CcSEcCtD
Carglumic Acid—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.00224	0.00314	CcSEcCtD
Carglumic Acid—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00224	0.00314	CcSEcCtD
Carglumic Acid—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00224	0.00314	CcSEcCtD
Carglumic Acid—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00223	0.00313	CcSEcCtD
Carglumic Acid—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00223	0.00313	CcSEcCtD
Carglumic Acid—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00223	0.00312	CcSEcCtD
Carglumic Acid—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00223	0.00312	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00223	0.00312	CcSEcCtD
Carglumic Acid—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00222	0.00312	CcSEcCtD
Carglumic Acid—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00222	0.00312	CcSEcCtD
Carglumic Acid—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00222	0.00311	CcSEcCtD
Carglumic Acid—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00221	0.00309	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.0022	0.00308	CcSEcCtD
Carglumic Acid—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.0022	0.00308	CcSEcCtD
Carglumic Acid—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00219	0.00307	CcSEcCtD
Carglumic Acid—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00219	0.00307	CcSEcCtD
Carglumic Acid—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00217	0.00305	CcSEcCtD
Carglumic Acid—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.00217	0.00304	CcSEcCtD
Carglumic Acid—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.00215	0.00302	CcSEcCtD
Carglumic Acid—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.00214	0.003	CcSEcCtD
Carglumic Acid—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00213	0.00298	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00211	0.00296	CcSEcCtD
Carglumic Acid—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00211	0.00295	CcSEcCtD
Carglumic Acid—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.0021	0.00293	CcSEcCtD
Carglumic Acid—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00209	0.00293	CcSEcCtD
Carglumic Acid—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00209	0.00292	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00208	0.00291	CcSEcCtD
Carglumic Acid—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.00207	0.0029	CcSEcCtD
Carglumic Acid—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00206	0.00289	CcSEcCtD
Carglumic Acid—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00205	0.00287	CcSEcCtD
Carglumic Acid—Rash—Didanosine—acquired immunodeficiency syndrome	0.00204	0.00286	CcSEcCtD
Carglumic Acid—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00204	0.00286	CcSEcCtD
Carglumic Acid—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00204	0.00286	CcSEcCtD
Carglumic Acid—Headache—Didanosine—acquired immunodeficiency syndrome	0.00203	0.00284	CcSEcCtD
Carglumic Acid—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00203	0.00284	CcSEcCtD
Carglumic Acid—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00202	0.00283	CcSEcCtD
Carglumic Acid—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00202	0.00283	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.002	0.0028	CcSEcCtD
Carglumic Acid—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.002	0.0028	CcSEcCtD
Carglumic Acid—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00199	0.00279	CcSEcCtD
Carglumic Acid—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00199	0.00279	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00199	0.00278	CcSEcCtD
Carglumic Acid—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00198	0.00277	CcSEcCtD
Carglumic Acid—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.00198	0.00277	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00197	0.00276	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00196	0.00275	CcSEcCtD
Carglumic Acid—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00196	0.00275	CcSEcCtD
Carglumic Acid—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00193	0.00271	CcSEcCtD
Carglumic Acid—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00193	0.00271	CcSEcCtD
Carglumic Acid—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00193	0.00271	CcSEcCtD
Carglumic Acid—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00193	0.0027	CcSEcCtD
Carglumic Acid—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00191	0.00268	CcSEcCtD
Carglumic Acid—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.0019	0.00266	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.0019	0.00266	CcSEcCtD
Carglumic Acid—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.00187	0.00262	CcSEcCtD
Carglumic Acid—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00187	0.00261	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00186	0.00261	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00186	0.0026	CcSEcCtD
Carglumic Acid—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00185	0.0026	CcSEcCtD
Carglumic Acid—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00185	0.00259	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00184	0.00257	CcSEcCtD
Carglumic Acid—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00184	0.00257	CcSEcCtD
Carglumic Acid—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00184	0.00257	CcSEcCtD
Carglumic Acid—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00183	0.00256	CcSEcCtD
Carglumic Acid—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00183	0.00256	CcSEcCtD
Carglumic Acid—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00182	0.00255	CcSEcCtD
Carglumic Acid—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00181	0.00254	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00181	0.00253	CcSEcCtD
Carglumic Acid—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.0018	0.00252	CcSEcCtD
Carglumic Acid—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.0018	0.00252	CcSEcCtD
Carglumic Acid—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.0018	0.00251	CcSEcCtD
Carglumic Acid—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.0018	0.00251	CcSEcCtD
Carglumic Acid—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00179	0.00251	CcSEcCtD
Carglumic Acid—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00179	0.0025	CcSEcCtD
Carglumic Acid—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00178	0.00249	CcSEcCtD
Carglumic Acid—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00178	0.00249	CcSEcCtD
Carglumic Acid—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00178	0.00249	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00178	0.00249	CcSEcCtD
Carglumic Acid—Rash—Stavudine—acquired immunodeficiency syndrome	0.00177	0.00249	CcSEcCtD
Carglumic Acid—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00177	0.00248	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00177	0.00248	CcSEcCtD
Carglumic Acid—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00177	0.00248	CcSEcCtD
Carglumic Acid—Headache—Stavudine—acquired immunodeficiency syndrome	0.00176	0.00247	CcSEcCtD
Carglumic Acid—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00176	0.00247	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00176	0.00246	CcSEcCtD
Carglumic Acid—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00176	0.00246	CcSEcCtD
Carglumic Acid—Rash—Abacavir—acquired immunodeficiency syndrome	0.00175	0.00245	CcSEcCtD
Carglumic Acid—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00175	0.00245	CcSEcCtD
Carglumic Acid—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00174	0.00244	CcSEcCtD
Carglumic Acid—Headache—Abacavir—acquired immunodeficiency syndrome	0.00174	0.00243	CcSEcCtD
Carglumic Acid—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00173	0.00243	CcSEcCtD
Carglumic Acid—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00171	0.0024	CcSEcCtD
Carglumic Acid—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.0017	0.00238	CcSEcCtD
Carglumic Acid—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.0017	0.00238	CcSEcCtD
Carglumic Acid—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.0017	0.00238	CcSEcCtD
Carglumic Acid—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00169	0.00237	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00169	0.00236	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00168	0.00236	CcSEcCtD
Carglumic Acid—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00167	0.00234	CcSEcCtD
Carglumic Acid—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.00166	0.00233	CcSEcCtD
Carglumic Acid—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00165	0.00232	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00164	0.0023	CcSEcCtD
Carglumic Acid—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00163	0.00229	CcSEcCtD
Carglumic Acid—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00163	0.00228	CcSEcCtD
Carglumic Acid—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00163	0.00228	CcSEcCtD
Carglumic Acid—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00163	0.00228	CcSEcCtD
Carglumic Acid—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00159	0.00223	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00158	0.00221	CcSEcCtD
Carglumic Acid—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00156	0.00218	CcSEcCtD
Carglumic Acid—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00156	0.00218	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00156	0.00218	CcSEcCtD
Carglumic Acid—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00155	0.00217	CcSEcCtD
Carglumic Acid—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00154	0.00216	CcSEcCtD
Carglumic Acid—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00154	0.00216	CcSEcCtD
Carglumic Acid—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00154	0.00216	CcSEcCtD
Carglumic Acid—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00153	0.00215	CcSEcCtD
Carglumic Acid—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.00152	0.00213	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00151	0.00211	CcSEcCtD
Carglumic Acid—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.0015	0.00211	CcSEcCtD
Carglumic Acid—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.0015	0.00211	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.0015	0.0021	CcSEcCtD
Carglumic Acid—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00148	0.00207	CcSEcCtD
Carglumic Acid—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00147	0.00206	CcSEcCtD
Carglumic Acid—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00145	0.00203	CcSEcCtD
Carglumic Acid—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00145	0.00203	CcSEcCtD
Carglumic Acid—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00145	0.00203	CcSEcCtD
Carglumic Acid—Rash—Indinavir—acquired immunodeficiency syndrome	0.00143	0.00201	CcSEcCtD
Carglumic Acid—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00143	0.00201	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00143	0.002	CcSEcCtD
Carglumic Acid—Headache—Indinavir—acquired immunodeficiency syndrome	0.00143	0.002	CcSEcCtD
Carglumic Acid—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00141	0.00197	CcSEcCtD
Carglumic Acid—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00138	0.00193	CcSEcCtD
Carglumic Acid—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00138	0.00193	CcSEcCtD
Carglumic Acid—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00137	0.00191	CcSEcCtD
Carglumic Acid—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00136	0.00191	CcSEcCtD
Carglumic Acid—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00136	0.0019	CcSEcCtD
Carglumic Acid—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00135	0.0019	CcSEcCtD
Carglumic Acid—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00135	0.00189	CcSEcCtD
Carglumic Acid—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00131	0.00184	CcSEcCtD
Carglumic Acid—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00131	0.00183	CcSEcCtD
Carglumic Acid—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.0013	0.00182	CcSEcCtD
Carglumic Acid—Rash—Delavirdine—acquired immunodeficiency syndrome	0.0013	0.00182	CcSEcCtD
Carglumic Acid—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.0013	0.00181	CcSEcCtD
Carglumic Acid—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00129	0.0018	CcSEcCtD
Carglumic Acid—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00125	0.00175	CcSEcCtD
Carglumic Acid—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00125	0.00175	CcSEcCtD
Carglumic Acid—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00121	0.00169	CcSEcCtD
Carglumic Acid—Rash—Ritonavir—acquired immunodeficiency syndrome	0.0012	0.00168	CcSEcCtD
Carglumic Acid—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.0012	0.00168	CcSEcCtD
Carglumic Acid—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00119	0.00167	CcSEcCtD
Carglumic Acid—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00119	0.00167	CcSEcCtD
Carglumic Acid—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00116	0.00163	CcSEcCtD
Carglumic Acid—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00115	0.00162	CcSEcCtD
Carglumic Acid—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00115	0.00161	CcSEcCtD
Carglumic Acid—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00115	0.00161	CcSEcCtD
Carglumic Acid—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00111	0.00155	CcSEcCtD
Carglumic Acid—Rash—Lamivudine—acquired immunodeficiency syndrome	0.0011	0.00154	CcSEcCtD
Carglumic Acid—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.0011	0.00154	CcSEcCtD
Carglumic Acid—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00109	0.00153	CcSEcCtD
